These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 23316186)

  • 1. Implication of inflammatory signaling pathways in obesity-induced insulin resistance.
    Tanti JF; Ceppo F; Jager J; Berthou F
    Front Endocrinol (Lausanne); 2012; 3():181. PubMed ID: 23316186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate sensors of pathogen and stress: linking inflammation to obesity.
    Jin C; Flavell RA
    J Allergy Clin Immunol; 2013 Aug; 132(2):287-94. PubMed ID: 23905917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NLRP3 inflammasome regulates adipose tissue metabolism.
    Barra NG; Henriksbo BD; Anhê FF; Schertzer JD
    Biochem J; 2020 Mar; 477(6):1089-1107. PubMed ID: 32202638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
    Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
    Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic signals and innate immune activation in obesity and exercise.
    Ringseis R; Eder K; Mooren FC; Krüger K
    Exerc Immunol Rev; 2015; 21():58-68. PubMed ID: 25825956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signalling Networks Governing Metabolic Inflammation.
    Dali-Youcef N; Ricci R
    Handb Exp Pharmacol; 2016; 233():195-220. PubMed ID: 25903413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of the Tpl2 kinase in inflammatory changes and insulin resistance induced by the interaction between adipocytes and macrophages.
    Ceppo F; Berthou F; Jager J; Dumas K; Cormont M; Tanti JF
    Endocrinology; 2014 Mar; 155(3):951-64. PubMed ID: 24424060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.
    Perfield JW; Lee Y; Shulman GI; Samuel VT; Jurczak MJ; Chang E; Xie C; Tsichlis PN; Obin MS; Greenberg AS
    Diabetes; 2011 Apr; 60(4):1168-76. PubMed ID: 21346175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocyte-Macrophage Cross-Talk in Obesity.
    Engin AB
    Adv Exp Med Biol; 2017; 960():327-343. PubMed ID: 28585206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes.
    Zatterale F; Longo M; Naderi J; Raciti GA; Desiderio A; Miele C; Beguinot F
    Front Physiol; 2019; 10():1607. PubMed ID: 32063863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue and insulin resistance in obese.
    Ahmed B; Sultana R; Greene MW
    Biomed Pharmacother; 2021 May; 137():111315. PubMed ID: 33561645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity.
    Camell CD; Nguyen KY; Jurczak MJ; Christian BE; Shulman GI; Shadel GS; Dixit VD
    J Biol Chem; 2015 Dec; 290(49):29402-13. PubMed ID: 26438821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota, inflammation and obesity.
    Sanz Y; Moya-Pérez A
    Adv Exp Med Biol; 2014; 817():291-317. PubMed ID: 24997040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice.
    Ohkura T; Yoshimura T; Fujisawa M; Ohara T; Marutani R; Usami K; Matsukawa A
    Front Immunol; 2019; 10():17. PubMed ID: 30723473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation.
    Engin A
    Adv Exp Med Biol; 2017; 960():221-245. PubMed ID: 28585201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD1 activators link innate immunity to insulin resistance.
    Schertzer JD; Tamrakar AK; Magalhães JG; Pereira S; Bilan PJ; Fullerton MD; Liu Z; Steinberg GR; Giacca A; Philpott DJ; Klip A
    Diabetes; 2011 Sep; 60(9):2206-15. PubMed ID: 21715553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors, inflammation, metabolism and obesity.
    Fresno M; Alvarez R; Cuesta N
    Arch Physiol Biochem; 2011 Jul; 117(3):151-64. PubMed ID: 21599616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
    Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance.
    Tamrakar AK; Schertzer JD; Chiu TT; Foley KP; Bilan PJ; Philpott DJ; Klip A
    Endocrinology; 2010 Dec; 151(12):5624-37. PubMed ID: 20926588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.